25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Agenus Inc
Buy, Hold or Sell?

Let's analyze Agenus Inc together

I guess you are interested in Agenus Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Agenus Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Agenus Inc

I send you an email if I find something interesting about Agenus Inc.

1. Quick Overview

1.1. Quick analysis of Agenus Inc (30 sec.)










1.2. What can you expect buying and holding a share of Agenus Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
7.5%

What is your share worth?

Current worth
$-4.05
Expected worth in 1 year
$-2.75
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$1.30
Return On Investment
34.8%

For what price can you sell your share?

Current Price per Share
$3.73
Expected price per share
$2.5 - $4.745
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Agenus Inc (5 min.)




Live pricePrice per Share (EOD)
$3.73
Intrinsic Value Per Share
$-419.39 - $-80.53
Total Value Per Share
$-423.44 - $-84.58

2.2. Growth of Agenus Inc (5 min.)




Is Agenus Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$87.3m-$75m-$86.7m-53.6%

How much money is Agenus Inc making?

Current yearPrevious yearGrowGrow %
Making money-$56.9m-$75.2m$18.2m32.1%
Net Profit Margin-191.6%-296.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Agenus Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#933 / 950

Most Revenue
#151 / 950

Most Profit
#857 / 950

Most Efficient
#519 / 950
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Agenus Inc?

Welcome investor! Agenus Inc's management wants to use your money to grow the business. In return you get a share of Agenus Inc.

First you should know what it really means to hold a share of Agenus Inc. And how you can make/lose money.

Speculation

The Price per Share of Agenus Inc is $3.73. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Agenus Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Agenus Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-4.05. Based on the TTM, the Book Value Change Per Share is $0.32 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Agenus Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-3.08-82.6%-2.64-70.7%-3.14-84.1%-2.05-54.9%-1.74-46.6%
Usd Book Value Change Per Share6.19165.9%0.328.7%-1.20-32.1%0.277.3%-0.16-4.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.1%0.000.0%0.246.5%
Usd Total Gains Per Share6.19165.9%0.328.7%-1.20-32.0%0.277.3%0.082.2%
Usd Price Per Share5.48-5.91-1.64-3.51-3.76-
Price to Earnings Ratio-0.44--0.57--0.13--0.33--0.51-
Price-to-Total Gains Ratio0.89--2.95-3.67--0.49-6.60-
Price to Book Ratio-1.35--0.79--0.55--0.10-0.12-
Price-to-Total Gains Ratio0.89--2.95-3.67--0.49-6.60-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.73
Number of shares268
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.320.27
Usd Total Gains Per Share0.320.27
Gains per Quarter (268 shares)86.8673.22
Gains per Year (268 shares)347.44292.88
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103473371292283
206956842584576
30104210312876869
4013901378311681162
5017371725414601455
6020852072517521748
7024322419620442041
8027802766723372334
9031273113726292627
10034743460829212920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%2.038.00.05.0%6.093.00.06.1%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%12.028.00.030.0%32.067.00.032.3%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%3.00.037.07.5%41.00.058.041.4%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%12.028.00.030.0%33.066.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Agenus Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--6.1890.324+1810%-1.199+119%0.272+2172%-0.158+103%
Book Value Per Share---4.048-7.497+85%-3.477-14%-5.482+35%-3.725-8%
Current Ratio--0.1850.307-40%0.919-80%0.981-81%2.047-91%
Debt To Asset Ratio--1.3661.584-14%1.201+14%1.544-12%1.414-3%
Debt To Equity Ratio----0%-0%8.881-100%5.587-100%
Dividend Per Share----0%0.004-100%0.001-100%0.241-100%
Eps---3.080-2.639-14%-3.137+2%-2.048-34%-1.738-44%
Free Cash Flow Per Share---2.447-1.911-22%-2.777+13%-1.786-27%-1.331-46%
Free Cash Flow To Equity Per Share---2.236-0.685-69%-1.198-46%-0.106-95%0.002-133773%
Gross Profit Margin--1.0000.974+3%1.0000%0.995+1%0.997+0%
Intrinsic Value_10Y_max---80.532--------
Intrinsic Value_10Y_min---419.395--------
Intrinsic Value_1Y_max---5.729--------
Intrinsic Value_1Y_min---14.972--------
Intrinsic Value_3Y_max---18.997--------
Intrinsic Value_3Y_min---68.683--------
Intrinsic Value_5Y_max---34.417--------
Intrinsic Value_5Y_min---147.956--------
Market Cap80463187.000-47%118214012.000127478603.753-7%35467978.683+233%75730851.438+56%81144751.181+46%
Net Profit Margin---2.646-1.916-28%-2.964+12%-2.6390%-4.515+71%
Operating Margin----0.5620%-2.0770%-1.6350%-3.1280%
Operating Ratio--2.3291.569+48%3.122-25%2.657-12%4.197-45%
Pb Ratio-0.921+32%-1.354-0.794-41%-0.548-60%-0.103-92%0.116-1266%
Pe Ratio-0.303+32%-0.445-0.573+29%-0.130-71%-0.326-27%-0.511+15%
Price Per Share3.730-47%5.4805.909-7%1.644+233%3.511+56%3.762+46%
Price To Free Cash Flow Ratio-0.381+32%-0.560-0.777+39%-0.151-73%-0.406-27%-0.421-25%
Price To Total Gains Ratio0.603-47%0.885-2.948+433%3.667-76%-0.495+156%6.600-87%
Quick Ratio--0.1660.282-41%0.909-82%0.922-82%2.176-92%
Return On Assets---0.279-0.212-24%-0.194-30%-0.179-36%-0.188-33%
Return On Equity----0%-0%-0.8320%-0.5830%
Total Gains Per Share--6.1890.324+1810%-1.195+119%0.273+2165%0.083+7368%
Usd Book Value---87326000.000-161717500.000+85%-75016000.000-14%-118267150.000+35%-80350433.850-8%
Usd Book Value Change Per Share--6.1890.324+1810%-1.199+119%0.272+2172%-0.158+103%
Usd Book Value Per Share---4.048-7.497+85%-3.477-14%-5.482+35%-3.725-8%
Usd Dividend Per Share----0%0.004-100%0.001-100%0.241-100%
Usd Eps---3.080-2.639-14%-3.137+2%-2.048-34%-1.738-44%
Usd Free Cash Flow---52796000.000-41223000.000-22%-59913750.000+13%-38518250.000-27%-28709368.175-46%
Usd Free Cash Flow Per Share---2.447-1.911-22%-2.777+13%-1.786-27%-1.331-46%
Usd Free Cash Flow To Equity Per Share---2.236-0.685-69%-1.198-46%-0.106-95%0.002-133773%
Usd Market Cap80463187.000-47%118214012.000127478603.753-7%35467978.683+233%75730851.438+56%81144751.181+46%
Usd Price Per Share3.730-47%5.4805.909-7%1.644+233%3.511+56%3.762+46%
Usd Profit---66440000.000-56924250.000-14%-75219250.000+13%-47615950.000-28%-38779000.050-42%
Usd Revenue--25112000.00040106750.000-37%25224500.0000%37464850.000-33%24837794.825+1%
Usd Total Gains Per Share--6.1890.324+1810%-1.195+119%0.273+2165%0.083+7368%
 EOD+1 -7MRQTTM+12 -19YOY+18 -145Y+18 -1610Y+15 -19

3.3 Fundamental Score

Let's check the fundamental score of Agenus Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.303
Price to Book Ratio (EOD)Between0-1-0.921
Net Profit Margin (MRQ)Greater than0-2.646
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.166
Current Ratio (MRQ)Greater than10.185
Debt to Asset Ratio (MRQ)Less than11.366
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.279
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Agenus Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.914
Ma 20Greater thanMa 503.357
Ma 50Greater thanMa 1004.152
Ma 100Greater thanMa 2005.327
OpenGreater thanClose3.450
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Agenus Inc

Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an antigen 4 (CTLA-4) blocking antibody that is in Phase 2 clinical trial for the treatment of pancreatic cancer and and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in Phase 1 clinical trial; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monospecific antibody; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; UGN-301, a zalifrelimab intravesical solution for the treatment of cancers of the urinary tract that is in a Phase 1 clinical trial; and AGEN1884, a first-generation anti-CTLA-4 monospecific antibody. The company operates under Agenus, MiNK, Prophage, Retrocyte Display, and Stimulon trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., Incyte Corporation, Merck Sharpe & Dohme, and Gilead Sciences, Inc. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Fundamental data was last updated by Penke on 2024-11-14 09:27:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Agenus Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Agenus Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -264.6% means that $-2.65 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Agenus Inc:

  • The MRQ is -264.6%. The company is making a huge loss. -2
  • The TTM is -191.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-264.6%TTM-191.6%-72.9%
TTM-191.6%YOY-296.4%+104.7%
TTM-191.6%5Y-263.9%+72.3%
5Y-263.9%10Y-451.5%+187.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-264.6%-112.2%-152.4%
TTM-191.6%-221.4%+29.8%
YOY-296.4%-210.0%-86.4%
5Y-263.9%-342.2%+78.3%
10Y-451.5%-464.5%+13.0%
4.3.1.2. Return on Assets

Shows how efficient Agenus Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Agenus Inc to the Biotechnology industry mean.
  • -27.9% Return on Assets means that Agenus Inc generated $-0.28 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Agenus Inc:

  • The MRQ is -27.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -21.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.9%TTM-21.2%-6.6%
TTM-21.2%YOY-19.4%-1.8%
TTM-21.2%5Y-17.9%-3.4%
5Y-17.9%10Y-18.8%+0.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.9%-11.3%-16.6%
TTM-21.2%-11.7%-9.5%
YOY-19.4%-11.3%-8.1%
5Y-17.9%-12.7%-5.2%
10Y-18.8%-14.1%-4.7%
4.3.1.3. Return on Equity

Shows how efficient Agenus Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Agenus Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Agenus Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Agenus Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-83.2%+83.2%
5Y-83.2%10Y-58.3%-24.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.2%+14.2%
TTM--15.9%+15.9%
YOY--14.3%+14.3%
5Y-83.2%-18.5%-64.7%
10Y-58.3%-19.3%-39.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Agenus Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Agenus Inc is operating .

  • Measures how much profit Agenus Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Agenus Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Agenus Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-56.2%+56.2%
TTM-56.2%YOY-207.7%+151.5%
TTM-56.2%5Y-163.5%+107.3%
5Y-163.5%10Y-312.8%+149.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--222.9%+222.9%
TTM-56.2%-310.7%+254.5%
YOY-207.7%-223.5%+15.8%
5Y-163.5%-387.1%+223.6%
10Y-312.8%-498.5%+185.7%
4.3.2.2. Operating Ratio

Measures how efficient Agenus Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.33 means that the operating costs are $2.33 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Agenus Inc:

  • The MRQ is 2.329. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.569. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.329TTM1.569+0.760
TTM1.569YOY3.122-1.553
TTM1.5695Y2.657-1.088
5Y2.65710Y4.197-1.540
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3292.465-0.136
TTM1.5693.253-1.684
YOY3.1223.298-0.176
5Y2.6574.788-2.131
10Y4.1976.494-2.297
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Agenus Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Agenus Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.19 means the company has $0.19 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Agenus Inc:

  • The MRQ is 0.185. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.307. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.185TTM0.307-0.122
TTM0.307YOY0.919-0.611
TTM0.3075Y0.981-0.674
5Y0.98110Y2.047-1.066
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1853.637-3.452
TTM0.3073.890-3.583
YOY0.9194.666-3.747
5Y0.9815.953-4.972
10Y2.0476.277-4.230
4.4.3.2. Quick Ratio

Measures if Agenus Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Agenus Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.17 means the company can pay off $0.17 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Agenus Inc:

  • The MRQ is 0.166. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.282. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.166TTM0.282-0.116
TTM0.282YOY0.909-0.626
TTM0.2825Y0.922-0.640
5Y0.92210Y2.176-1.254
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1663.086-2.920
TTM0.2823.451-3.169
YOY0.9094.456-3.547
5Y0.9225.931-5.009
10Y2.1766.436-4.260
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Agenus Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Agenus Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Agenus Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.37 means that Agenus Inc assets are financed with 136.6% credit (debt) and the remaining percentage (100% - 136.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Agenus Inc:

  • The MRQ is 1.366. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.584. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.366TTM1.584-0.218
TTM1.584YOY1.201+0.383
TTM1.5845Y1.544+0.039
5Y1.54410Y1.414+0.130
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3660.350+1.016
TTM1.5840.344+1.240
YOY1.2010.310+0.891
5Y1.5440.365+1.179
10Y1.4140.382+1.032
4.5.4.2. Debt to Equity Ratio

Measures if Agenus Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Agenus Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Agenus Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y8.881-8.881
5Y8.88110Y5.587+3.294
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.394-0.394
TTM-0.432-0.432
YOY-0.380-0.380
5Y8.8810.451+8.430
10Y5.5870.490+5.097
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Agenus Inc generates.

  • Above 15 is considered overpriced but always compare Agenus Inc to the Biotechnology industry mean.
  • A PE ratio of -0.44 means the investor is paying $-0.44 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Agenus Inc:

  • The EOD is -0.303. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.445. Based on the earnings, the company is expensive. -2
  • The TTM is -0.573. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.303MRQ-0.445+0.142
MRQ-0.445TTM-0.573+0.129
TTM-0.573YOY-0.130-0.444
TTM-0.5735Y-0.326-0.247
5Y-0.32610Y-0.511+0.185
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.303-2.303+2.000
MRQ-0.445-2.403+1.958
TTM-0.573-3.148+2.575
YOY-0.130-3.251+3.121
5Y-0.326-6.084+5.758
10Y-0.511-6.764+6.253
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Agenus Inc:

  • The EOD is -0.381. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.560. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.777. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.381MRQ-0.560+0.179
MRQ-0.560TTM-0.777+0.217
TTM-0.777YOY-0.151-0.625
TTM-0.7775Y-0.406-0.370
5Y-0.40610Y-0.421+0.014
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.381-3.042+2.661
MRQ-0.560-3.234+2.674
TTM-0.777-3.719+2.942
YOY-0.151-4.557+4.406
5Y-0.406-8.332+7.926
10Y-0.421-9.276+8.855
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Agenus Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -1.35 means the investor is paying $-1.35 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Agenus Inc:

  • The EOD is -0.921. Based on the equity, the company is expensive. -2
  • The MRQ is -1.354. Based on the equity, the company is expensive. -2
  • The TTM is -0.794. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.921MRQ-1.354+0.432
MRQ-1.354TTM-0.794-0.560
TTM-0.794YOY-0.548-0.246
TTM-0.7945Y-0.103-0.691
5Y-0.10310Y0.116-0.219
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.9211.943-2.864
MRQ-1.3542.051-3.405
TTM-0.7942.356-3.150
YOY-0.5482.454-3.002
5Y-0.1033.714-3.817
10Y0.1164.378-4.262
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Agenus Inc.

4.8.1. Institutions holding Agenus Inc

Institutions are holding 40.564% of the shares of Agenus Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30Vanguard Group Inc9.98870.0007215475421547540
2024-06-30BlackRock Inc7.17640.0006154808015480800
2024-06-30Morgan Stanley - Brokerage Accounts3.78460.00058164208164200
2024-06-30Artal Group S A3.59260.33097750007750000
2024-06-30State Street Corp2.12330.00034580404580400
2024-06-30Geode Capital Management, LLC2.09090.00074510434510430
2024-06-30Deep Track Capital, LP1.45260.15673133593133590
2024-06-30Point72 Asset Management, L.P.1.20850.01142607002607000
2024-06-30Renaissance Technologies Corp1.1790.00722543292543290
2024-06-30Amvescap Plc.1.12460.00092425992425990
2024-06-30Charles Schwab Investment Management Inc0.73580.00051587171587170
2024-06-30Northern Trust Corp0.70820.00041527691527690
2024-06-30Federated Hermes Inc0.53160.00461146771146770
2024-06-30Woodline Partners LP0.51090.01761102071102070
2024-06-30Wellington Management Company LLP0.42820.000392363923630
2024-06-30Bank of New York Mellon Corp0.41530.000389599895990
2024-06-30UBS O'Connor LLC0.34850.078475189751890
2024-06-30Connor Clark & Lunn Inv Mgmt Ltd0.33480.005172228722280
2024-09-30Key Client Fiduciary Advisors, LLC0.31250.165367416-2338-3.3518
2024-06-30Susquehanna Fundamental Investments, LLC0.29070.024262703627030
Total 38.33770.80668270192+8200438+99.2%

4.9.2. Funds holding Agenus Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Vanguard Total Stock Mkt Idx Inv3.03590.000265490500
2024-10-31iShares Russell 2000 ETF2.4290.0033523976-1176-0.2239
2024-09-30Vanguard Strategic Equity Inv2.37260.03151180900
2024-09-30Vanguard Explorer Inv1.34730.007129064600
2024-09-30Vanguard Institutional Extnd Mkt Idx Tr1.25420.001427054600
2024-08-31Fidelity Small Cap Index0.96120.0039207358-5097-2.3991
2024-09-30Vanguard Strategic Small-Cap Equity Inv0.95190.06342053458440869.795
2024-10-31State St Russell Sm/Mid Cp® Indx NL Cl C0.83940.0017181072-4300-2.3197
2024-10-31iShares Russell 2000 Value ETF0.77160.005716645100
2024-10-31Selectra J. Lamarck Biotech A0.66710.721314390200
2024-09-30Fidelity Extended Market Index0.58020.0016125168111399.7686
2024-09-30Vanguard VIF Small Co Gr0.51350.03891107623170440.1022
2024-09-30Federated Hermes MDT Small Cap Core IS0.50910.04321098183285742.6931
2024-09-30Federated Hermes MDT SCC Institutional0.50910.04321098183285742.6931
2024-09-30Federated Hermes MDT SCG Institutional0.46270.10839981268626220.0539
2024-09-30Federated Hermes MDT Small Cap Growth IS0.46270.10839981268626220.0539
2024-09-30Vanguard Russell 2000 ETF0.45340.0043978041597919.5283
2024-10-31State St Russell Sm Cap® Indx SL Cl I0.30920.00296670800
2024-09-30Vanguard Health Care ETF0.27560.001559442-189-0.3169
2024-10-31Fidelity Enhanced Small Cap ETF0.23560.023550823-354-0.6917
Total 18.94131.21474085977+335080+8.2%

5.3. Insider Transactions

Insiders are holding 1.328% of the shares of Agenus Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-15Garo H ArmenBUY2500013
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Operating Income  -46,34141,982-4,359-28,523-32,8822,689-30,19330,21219
Interest Expense  18,63325,94144,574-15,10829,4662,27931,745-67,474-35,729



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets238,482
Total Liabilities325,808
Total Stockholder Equity-87,326
 As reported
Total Liabilities 325,808
Total Stockholder Equity+ -87,326
Total Assets = 238,482

Assets

Total Assets238,482
Total Current Assets50,154
Long-term Assets188,328
Total Current Assets
Cash And Cash Equivalents 44,784
Net Receivables 207
Other Current Assets 5,163
Total Current Assets  (as reported)50,154
Total Current Assets  (calculated)50,154
+/-0
Long-term Assets
Property Plant Equipment 155,511
Goodwill 24,694
Intangible Assets 3,955
Long-term Assets Other 4,168
Long-term Assets  (as reported)188,328
Long-term Assets  (calculated)188,328
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities270,644
Long-term Liabilities55,164
Total Stockholder Equity-87,326
Total Current Liabilities
Accounts payable 45,899
Other Current Liabilities 224,735
Total Current Liabilities  (as reported)270,644
Total Current Liabilities  (calculated)270,634
+/- 10
Long-term Liabilities
Long-term Liabilities  (as reported)55,164
Long-term Liabilities  (calculated)0
+/- 55,164
Total Stockholder Equity
Common Stock217
Retained Earnings -2,137,021
Accumulated Other Comprehensive Income -1,347
Other Stockholders Equity 2,050,825
Total Stockholder Equity (as reported)-87,326
Total Stockholder Equity (calculated)-87,326
+/-0
Other
Cash and Short Term Investments 44,784
Common Stock Shares Outstanding 21,550
Current Deferred Revenue10
Liabilities and Stockholders Equity 238,482
Net Debt 10,380
Net Working Capital -220,490
Short Long Term Debt Total 55,164



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
119,024
115,191
112,098
127,966
119,251
111,872
105,612
93,546
136,490
117,820
103,998
89,063
135,235
122,120
152,442
140,080
180,905
167,830
152,091
133,058
161,983
142,559
121,721
104,151
84,019
69,130
59,679
72,952
62,967
55,236
52,636
44,537
60,218
72,140
62,503
56,945
46,711
39,687
51,350
45,874
39,120
42,106
36,616
30,907
26,427
22,231
24,369
19,808
33,205
33,269
32,224
34,673
30,713
21,371
37,670
34,835
108,304
100,188
87,632
74,527
117,324
180,110
242,608
242,228
221,139
196,454
174,842
156,986
203,269
176,491
149,270
138,402
130,816
131,936
130,475
136,401
245,933
206,707
174,807
155,335
180,055
185,784
204,483
214,514
234,915
192,299
437,639
465,958
441,305
456,174
429,019
413,556
412,854
383,593
335,472
313,913
256,559
292,415
238,482
238,482292,415256,559313,913335,472383,593412,854413,556429,019456,174441,305465,958437,639192,299234,915214,514204,483185,784180,055155,335174,807206,707245,933136,401130,475131,936130,816138,402149,270176,491203,269156,986174,842196,454221,139242,228242,608180,110117,32474,52787,632100,188108,30434,83537,67021,37130,71334,67332,22433,26933,20519,80824,36922,23126,42730,90736,61642,10639,12045,87451,35039,68746,71156,94562,50372,14060,21844,53752,63655,23662,96772,95259,67969,13084,019104,151121,721142,559161,983133,058152,091167,830180,905140,080152,442122,120135,23589,063103,998117,820136,49093,546105,612111,872119,251127,966112,098115,191119,024
   > Total Current Assets 
110,508
106,221
102,743
101,593
93,082
85,825
75,505
63,987
106,314
88,392
75,812
63,400
108,107
87,384
107,387
93,322
138,853
127,580
112,464
92,604
120,450
102,277
82,778
66,962
48,933
35,360
27,151
42,298
35,155
28,784
27,123
20,782
37,794
50,825
42,349
35,486
26,396
23,274
35,967
31,533
26,400
30,298
25,635
20,854
16,914
13,296
15,985
12,004
25,952
26,477
24,758
22,615
18,346
14,446
30,876
28,175
75,260
67,032
55,219
42,670
85,154
146,283
208,943
184,095
161,613
136,069
109,526
91,312
137,950
110,690
84,344
73,554
65,193
67,705
67,636
74,808
179,123
138,938
107,186
86,536
102,774
104,759
125,451
113,783
135,663
92,854
308,401
331,974
290,483
288,934
251,432
213,122
205,689
170,735
125,550
112,416
60,352
100,004
50,154
50,154100,00460,352112,416125,550170,735205,689213,122251,432288,934290,483331,974308,40192,854135,663113,783125,451104,759102,77486,536107,186138,938179,12374,80867,63667,70565,19373,55484,344110,690137,95091,312109,526136,069161,613184,095208,943146,28385,15442,67055,21967,03275,26028,17530,87614,44618,34622,61524,75826,47725,95212,00415,98513,29616,91420,85425,63530,29826,40031,53335,96723,27426,39635,48642,34950,82537,79420,78227,12328,78435,15542,29827,15135,36048,93366,96282,778102,277120,45092,604112,464127,580138,85393,322107,38787,384108,10763,40075,81288,392106,31463,98775,50585,82593,082101,593102,743106,221110,508
       Cash And Cash Equivalents 
109,389
105,141
101,553
96,143
90,078
81,622
71,748
60,867
102,743
55,919
43,595
33,130
70,838
59,022
77,892
57,212
72,244
48,355
37,477
15,980
40,588
42,255
35,783
33,217
26,745
19,415
15,515
24,219
20,938
22,851
21,614
14,479
35,410
39,087
30,919
24,469
14,592
16,059
29,011
20,067
13,940
18,746
14,408
19,782
10,631
12,016
14,732
10,748
24,585
25,456
24,758
21,468
17,214
13,445
30,205
27,352
73,491
62,815
38,386
40,224
79,304
139,642
199,133
171,668
148,230
123,293
95,399
76,437
113,864
96,766
65,075
60,187
52,348
43,164
46,169
53,054
158,306
121,717
93,274
61,808
92,284
79,171
114,144
99,871
119,366
73,543
256,529
291,931
247,709
228,385
208,354
178,674
164,819
143,205
106,305
76,110
52,856
93,723
44,784
44,78493,72352,85676,110106,305143,205164,819178,674208,354228,385247,709291,931256,52973,543119,36699,871114,14479,17192,28461,80893,274121,717158,30653,05446,16943,16452,34860,18765,07596,766113,86476,43795,399123,293148,230171,668199,133139,64279,30440,22438,38662,81573,49127,35230,20513,44517,21421,46824,75825,45624,58510,74814,73212,01610,63119,78214,40818,74613,94020,06729,01116,05914,59224,46930,91939,08735,41014,47921,61422,85120,93824,21915,51519,41526,74533,21735,78342,25540,58815,98037,47748,35572,24457,21277,89259,02270,83833,13043,59555,919102,74360,86771,74881,62290,07896,143101,553105,141109,389
       Short-term Investments 
0
0
0
2,997
2,997
0
0
0
0
28,478
26,868
25,595
32,227
24,686
25,820
32,266
59,675
69,129
68,790
70,941
73,476
54,315
41,436
28,531
17,714
12,452
8,874
15,876
11,336
2,587
3,250
4,200
4,200
9,963
9,955
9,994
9,993
4,998
4,998
9,998
9,997
9,996
9,997
0
4,999
0
0
0
0
0
0
0
0
0
0
0
0
14,545
14,521
14,510
14,510
14,977
14,994
34,965
69,899
49,895
19,961
4,989
9,960
14,936
4,976
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,999
14,992
14,978
9,945
9,876
14,684
24,414
14,647
0
0
0
2,141
0
02,14100014,64724,41414,6849,8769,94514,97814,9924,9990000000000000004,97614,9369,9604,98919,96149,89569,89934,96514,99414,97714,51014,51014,52114,5450000000000004,99909,9979,9969,9979,9984,9984,9989,9939,9949,9559,9634,2004,2003,2502,58711,33615,8768,87412,45217,71428,53141,43654,31573,47670,94168,79069,12959,67532,26625,82024,68632,22725,59526,86828,47800002,9972,997000
       Net Receivables 
0
0
0
533
865
1,121
693
487
641
558
862
1,116
1,219
543
800
590
324
1
18
76
105
104
4,945
46
3,989
2,935
122
182
377
166
324
319
308
3
870
610
1,055
443
325
752
307
18
35
35
865
0
772
536
59
92
369
552
164
202
1
1
1
1,133
1,430
1,248
2,534
4,111
7,332
9,800
10,224
9,417
10,284
11,352
6,775
3,944
2,191
1,134
1,129
10,920
6,069
938
796
2,205
2,328
16,293
2,643
16,628
1,414
1,157
2,173
1,436
21,773
1,518
1,286
18,994
8,823
2,741
1,417
1,341
1,030
25,836
476
719
207
20771947625,8361,0301,3411,4172,7418,82318,9941,2861,51821,7731,4362,1731,1571,41416,6282,64316,2932,3282,2057969386,06910,9201,1291,1342,1913,9446,77511,35210,2849,41710,2249,8007,3324,1112,5341,2481,4301,133111202164552369925953677208653535183077523254431,05561087033083193241663771821222,9353,989464,945104105761813245908005431,2191,1168625586414876931,121865533000
       Other Current Assets 
1,119
1,080
1,190
1,251
444
775
402
620
462
842
1,380
889
819
433
347
483
691
5,023
3,901
647
539
455
410
291
288
250
432
275
203
1,258
250
436
297
363
379
187
529
534
694
392
974
587
415
306
394
422
455
700
485
218
15
32
65
56
12
163
444
2,989
786
1,103
747
619
437
582
289
507
726
839
635
951
1,237
1,082
598
650
812
1,496
1,851
1,409
1,088
1,015
918
1,296
1,661
2,009
3,446
4,247
6,758
3,171
4,780
2,988
2,390
3,194
3,896
2,843
2,329
10,470
7,020
5,562
5,163
5,1635,5627,02010,4702,3292,8433,8963,1942,3902,9884,7803,1716,7584,2473,4462,0091,6611,2969181,0151,0881,4091,8511,4968126505981,0821,2379516358397265072895824376197471,1037862,98944416312566532152184857004554223943064155879743926945345291873793632974362501,2582032754322502882914104555396473,9015,0236914833474338198891,3808424626204027754441,2511,1901,0801,119
   > Long-term Assets 
8,516
8,970
9,355
26,373
26,169
26,047
30,107
29,559
30,176
29,428
28,186
25,663
27,128
34,736
45,055
46,758
42,052
40,250
39,627
40,454
41,533
40,282
38,943
37,189
35,086
33,770
32,528
30,653
27,812
26,452
25,512
23,755
22,424
21,315
20,154
21,459
20,315
16,413
15,384
14,341
12,721
11,808
10,981
10,052
9,513
8,936
8,384
7,803
7,253
6,792
7,466
9,084
6,787
6,925
6,794
9,446
33,044
33,156
32,413
31,857
32,170
33,826
33,664
58,133
59,526
60,386
65,315
65,674
65,318
65,801
64,927
82,201
65,623
64,232
62,839
61,593
66,810
67,769
67,621
68,799
77,281
81,025
79,032
100,731
99,252
99,445
129,238
133,984
150,822
167,240
177,587
200,434
207,165
212,858
209,922
201,497
196,207
192,411
188,328
188,328192,411196,207201,497209,922212,858207,165200,434177,587167,240150,822133,984129,23899,44599,252100,73179,03281,02577,28168,79967,62167,76966,81061,59362,83964,23265,62382,20164,92765,80165,31865,67465,31560,38659,52658,13333,66433,82632,17031,85732,41333,15633,0449,4466,7946,9256,7879,0847,4666,7927,2537,8038,3848,9369,51310,05210,98111,80812,72114,34115,38416,41320,31521,45920,15421,31522,42423,75525,51226,45227,81230,65332,52833,77035,08637,18938,94340,28241,53340,45439,62740,25042,05246,75845,05534,73627,12825,66328,18629,42830,17629,55930,10726,04726,16926,3739,3558,9708,516
       Property Plant Equipment 
8,068
8,229
8,624
14,640
14,399
14,404
14,293
13,934
14,906
14,212
13,425
11,370
12,903
20,674
24,651
25,033
24,877
24,081
24,396
24,988
25,134
25,000
24,453
23,350
21,627
20,645
19,512
18,619
17,603
16,594
15,581
14,604
13,629
12,876
12,260
11,535
10,828
10,131
9,432
8,891
8,220
7,518
6,878
6,194
5,664
5,095
4,714
4,137
3,586
3,108
2,750
5,212
2,915
2,897
2,887
5,570
4,136
4,543
5,228
5,997
5,880
6,952
7,830
15,311
16,588
18,224
23,508
25,634
25,461
25,575
25,635
26,179
27,036
26,922
25,839
25,116
31,039
32,105
32,713
33,690
42,530
43,535
41,702
60,270
60,734
60,992
81,525
91,083
105,919
127,158
138,854
164,286
171,463
173,886
169,697
163,027
159,670
156,533
155,511
155,511156,533159,670163,027169,697173,886171,463164,286138,854127,158105,91991,08381,52560,99260,73460,27041,70243,53542,53033,69032,71332,10531,03925,11625,83926,92227,03626,17925,63525,57525,46125,63423,50818,22416,58815,3117,8306,9525,8805,9975,2284,5434,1365,5702,8872,8972,9155,2122,7503,1083,5864,1374,7145,0955,6646,1946,8787,5188,2208,8919,43210,13110,82811,53512,26012,87613,62914,60415,58116,59417,60318,61919,51220,64521,62723,35024,45325,00025,13424,98824,39624,08124,87725,03324,65120,67412,90311,37013,42514,21214,90613,93414,29314,40414,39914,6408,6248,2298,068
       Goodwill 
0
0
0
2,962
0
0
0
2,756
3,082
3,082
3,082
3,081,703
3,082
3,082
3,082
3,081,703
3,082
3,082
3,081,703
2,572,203
2,572
2,572
2,572
2,572,203
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
19,636
19,551
18,482
17,869
18,269
18,774
18,140
22,793
23,268
23,015
23,165
22,392
22,668
23,352
23,079
23,049
23,398
22,814
22,959
22,925
22,751
23,034
22,757
23,188
23,264
24,276
24,694
25,452
24,334
24,706
24,528
24,876
24,617
24,438
23,936
25,467
25,623
24,728
24,666
24,723
24,698
24,748
24,694
24,69424,74824,69824,72324,66624,72825,62325,46723,93624,43824,61724,87624,52824,70624,33425,45224,69424,27623,26423,18822,75723,03422,75122,92522,95922,81423,39823,04923,07923,35222,66822,39223,16523,01523,26822,79318,14018,77418,26917,86918,48219,55119,6362,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,572,2032,5722,5722,5722,572,2033,081,7033,0823,0823,081,7033,0823,0823,0823,081,7033,0823,0823,0822,7560002,962000
       Intangible Assets 
0
0
0
2,962
9,334
9,062
13,345
2,756
12,991
12,722
12,453
3,082
11,876
11,599
11,323
11,046
10,770
3,082
3,082
9,428
9,151
8,874
8,598
2,594
5,472
5,195
4,918
4,641
4,364
4,088
3,811
3,534
3,257
2,980
2,704
3,267
2,150
1,873
1,596
1,613
413
258
103
30
30
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
2,572
7,998
7,812
7,183
6,774
6,815
6,895
6,490
18,759
18,388
17,724
17,218
16,365
15,907
15,591
14,930
31,759
13,975
13,281
12,827
12,338
11,806
11,416
10,853
10,504
10,047
11,760
11,146
10,886
9,994
9,594
8,993
8,488
7,753
7,722
6,877
6,228
5,660
4,986
4,497
4,411
4,230
4,136
3,955
3,9554,1364,2304,4114,4974,9865,6606,2286,8777,7227,7538,4888,9939,5949,99410,88611,14611,76010,04710,50410,85311,41611,80612,33812,82713,28113,97531,75914,93015,59115,90716,36517,21817,72418,38818,7596,4906,8956,8156,7747,1837,8127,9982,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,57230301032584131,6131,5961,8732,1503,2672,7042,9803,2573,5343,8114,0884,3644,6414,9185,1955,4722,5948,5988,8749,1519,4283,0823,08210,77011,04611,32311,59911,8763,08212,45312,72212,9912,75613,3459,0629,3342,962000
       Long-term Assets Other 
449
741
731
8,770
2,436
2,581
2,470
12,869
2,279
2,494
2,309
11,212
2,349
2,463
9,081
10,678
6,405
13,087
12,150
6,038
7,248
6,408
5,893
11,244
5,415
5,358
5,525
4,821
3,273
3,198
3,548
3,044
2,966
2,886
2,618
4,083
4,765
1,837
1,783
1,265
1,515
1,460
1,428
1,256
1,277
1,268
1,098
1,095
1,095
1,112
2,144
1,299
1,299
1,455
1,334
1,304
1,275
1,250
1,520
1,217
1,207
1,205
1,205
1,270
1,283
1,424
1,424
1,283
1,283
1,283
1,283
1,214
1,214
1,214
1,214
1,214
1,214
1,214
1,298
1,417
1,440
1,454
1,490
4,123
1,521
1,484
11,523
6,868
9,864
7,922
7,920
4,453
4,419
9,258
11,062
5,667
3,940
5,501
4,168
4,1685,5013,9405,66711,0629,2584,4194,4537,9207,9229,8646,86811,5231,4841,5214,1231,4901,4541,4401,4171,2981,2141,2141,2141,2141,2141,2141,2141,2831,2831,2831,2831,4241,4241,2831,2701,2051,2051,2071,2171,5201,2501,2751,3041,3341,4551,2991,2992,1441,1121,0951,0951,0981,2681,2771,2561,4281,4601,5151,2651,7831,8374,7654,0832,6182,8862,9663,0443,5483,1983,2734,8215,5255,3585,41511,2445,8936,4087,2486,03812,15013,0876,40510,6789,0812,4632,34911,2122,3092,4942,27912,8692,4702,5812,4368,770731741449
> Total Liabilities 
4,534
4,480
5,417
11,262
9,083
9,275
16,391
17,621
15,869
11,126
10,787
11,306
11,364
13,133
29,427
34,834
38,890
28,644
28,795
26,615
73,809
75,573
71,924
72,252
67,935
66,084
66,653
90,345
88,158
89,743
92,132
91,597
90,756
92,069
92,392
80,863
77,409
68,269
70,260
62,849
63,528
61,850
61,696
45,614
38,884
39,383
40,439
40,638
43,837
44,628
45,381
46,693
47,817
38,634
40,547
39,316
45,019
42,555
38,761
51,509
71,065
92,920
165,632
171,500
176,686
179,577
195,881
196,112
194,364
193,972
200,865
214,218
244,049
245,023
261,868
310,946
365,216
368,317
379,679
386,672
382,555
411,748
410,806
426,012
432,864
448,051
402,086
418,049
413,655
442,536
440,855
468,458
465,963
460,354
450,764
462,295
446,882
513,254
325,808
325,808513,254446,882462,295450,764460,354465,963468,458440,855442,536413,655418,049402,086448,051432,864426,012410,806411,748382,555386,672379,679368,317365,216310,946261,868245,023244,049214,218200,865193,972194,364196,112195,881179,577176,686171,500165,63292,92071,06551,50938,76142,55545,01939,31640,54738,63447,81746,69345,38144,62843,83740,63840,43939,38338,88445,61461,69661,85063,52862,84970,26068,26977,40980,86392,39292,06990,75691,59792,13289,74388,15890,34566,65366,08467,93572,25271,92475,57373,80926,61528,79528,64438,89034,83429,42713,13311,36411,30610,78711,12615,86917,62116,3919,2759,08311,2625,4174,4804,534
   > Total Current Liabilities 
2,601
2,778
3,954
8,611
6,819
7,786
15,518
16,207
14,687
9,979
9,683
9,971
9,501
11,342
19,603
22,105
27,925
18,517
20,027
19,204
17,629
20,790
18,324
19,145
14,860
13,207
10,824
9,078
6,993
7,668
8,375
8,383
7,922
8,507
9,079
6,997
6,062
6,639
6,187
5,355
5,774
4,847
40,184
5,416
5,579
4,807
5,865
4,754
5,508
4,588
45,381
4,813
5,778
7,176
9,653
10,296
14,373
18,569
15,610
9,229
20,999
25,321
28,286
28,934
31,258
33,063
34,849
40,851
36,354
32,912
54,407
56,438
30,162
51,317
58,190
68,062
105,511
121,739
132,948
122,209
127,342
142,272
146,895
129,884
138,374
168,754
150,131
156,943
163,062
159,723
173,073
188,952
190,898
204,068
198,356
255,897
256,002
270,666
270,644
270,644270,666256,002255,897198,356204,068190,898188,952173,073159,723163,062156,943150,131168,754138,374129,884146,895142,272127,342122,209132,948121,739105,51168,06258,19051,31730,16256,43854,40732,91236,35440,85134,84933,06331,25828,93428,28625,32120,9999,22915,61018,56914,37310,2969,6537,1765,7784,81345,3814,5885,5084,7545,8654,8075,5795,41640,1844,8475,7745,3556,1876,6396,0626,9979,0798,5077,9228,3838,3757,6686,9939,07810,82413,20714,86019,14518,32420,79017,62919,20420,02718,51727,92522,10519,60311,3429,5019,9719,6839,97914,68716,20715,5187,7866,8198,6113,9542,7782,601
       Short-term Debt 
843
874
906
2,335
2,217
2,441
5,748
5,901
5,384
2,111
1,194
539
285
225
4,305
5,623
5,687
5,304
5,357
5,410
5,464
5,518
5,292
4,126
2,695
1,204
359
146
146
146
146
146
146
146
146
146
146
146
146
146
146
146
32,563
146
146
146
196
198
203
212
210
204
201
2,434
3,259
3,519
4,083
7,429
6,716
1,257
424
146
146
146
146
146
146
146
146
146
19,956
20,640
146
146
146
146
15,001
14,923
15,158
1,993
2,152
3,182
2,995
2,783
3,521
3,096
2,910
3,355
16,889
15,615
15,356
2,518
12,267
12,421
13,136
145,692
27,124
25,088
0
025,08827,124145,69213,13612,42112,2672,51815,35615,61516,8893,3552,9103,0963,5212,7832,9953,1822,1521,99315,15814,92315,00114614614614620,64019,9561461461461461461461461461464241,2576,7167,4294,0833,5193,2592,43420120421021220319819614614614632,5631461461461461461461461461461461461461461461463591,2042,6954,1265,2925,5185,4645,4105,3575,3045,6875,6234,3052252855391,1942,1115,3845,9015,7482,4412,2172,335906874843
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,257
0
0
0
146
0
146
146
146
146
139,142
19,956
20,640
146
146
146
146
13,517
13,679
13,847
646
646
1,532
1,182
833
1,463
838
542
728
14,181
13,699
13,458
575
1,022
622
387
146
13,575
13,425
0
013,42513,5751463876221,02257513,45813,69914,1817285428381,4638331,1821,53264664613,84713,67913,51714614614614620,64019,956139,14214614614614601460001,25700000000000000000000000000000000000000000000000000000000000
       Accounts payable 
1,055
1,024
1,710
2,274
1,970
2,060
3,377
2,948
2,249
1,190
1,398
1,435
843
1,036
1,778
3,180
1,016
1,040
898
2,924
1,021
1,388
1,739
2,590
1,995
2,188
2,209
1,090
661
326
987
674
735
334
699
541
590
717
661
895
431
335
281
699
450
340
504
808
340
632
468
635
582
422
365
835
1,681
930
2,259
1,711
3,973
2,662
3,091
4,489
2,513
5,022
3,268
5,428
4,818
4,572
6,719
8,087
5,407
10,234
11,146
13,624
12,734
19,052
16,424
13,564
14,752
20,698
20,543
17,015
19,477
19,164
25,118
30,486
34,544
41,002
39,711
40,939
46,768
52,473
40,871
61,446
50,693
50,843
45,899
45,89950,84350,69361,44640,87152,47346,76840,93939,71141,00234,54430,48625,11819,16419,47717,01520,54320,69814,75213,56416,42419,05212,73413,62411,14610,2345,4078,0876,7194,5724,8185,4283,2685,0222,5134,4893,0912,6623,9731,7112,2599301,6818353654225826354686323408085043404506992813354318956617175905416993347356749873266611,0902,2092,1881,9952,5901,7391,3881,0212,9248981,0401,0163,1801,7781,0368431,4351,3981,1902,2492,9483,3772,0601,9702,2741,7101,0241,055
       Other Current Liabilities 
703
880
1,338
4,003
2,632
3,284
6,392
7,358
7,053
6,678
7,091
7,996
8,373
10,082
13,520
2,000
10,418
104
9
9
47
47
47
138
898
582
-3,067,400
256
408
877
671
6,149
5,646
6,639
7,004
4,828
3,881
4,341
3,945
2,812
3,649
2,918
6,135
3,031
3,443
2,781
3,615
2,206
3,430
2,505
43,708
2,446
3,467
2,810
4,518
4,282
5,577
7,683
5,446
6,077
7,016
14,736
19,081
20,470
25,443
25,266
28,824
32,666
28,780
25,549
25,503
23,227
23,461
39,991
46,055
52,478
50,536
58,224
67,136
77,478
76,216
81,055
83,239
92,900
92,550
118,341
102,421
110,677
98,102
88,911
105,244
133,226
121,977
131,346
139,355
48,741
178,172
194,726
224,735
224,735194,726178,17248,741139,355131,346121,977133,226105,24488,91198,102110,677102,421118,34192,55092,90083,23981,05576,21677,47867,13658,22450,53652,47846,05539,99123,46123,22725,50325,54928,78032,66628,82425,26625,44320,47019,08114,7367,0166,0775,4467,6835,5774,2824,5182,8103,4672,44643,7082,5053,4302,2063,6152,7813,4433,0316,1352,9183,6492,8123,9454,3413,8814,8287,0046,6395,6466,149671877408256-3,067,4005828981384747479910410,4182,00013,52010,0828,3737,9967,0916,6787,0537,3586,3923,2842,6324,0031,338880703
   > Long-term Liabilities 
1,933
1,702
1,463
2,651
2,264
1,489
873
1,414
1,183
1,146
1,104
1,335
1,863
1,791
9,824
12,729
10,965
10,128
8,768
7,411
56,180
54,783
53,600
53,106
53,075
52,877
55,829
81,267
81,165
82,074
83,757
83,215
82,834
83,562
83,313
73,866
71,347
61,630
64,073
57,494
57,754
57,003
21,513
40,198
33,305
34,577
34,574
35,885
38,329
40,041
40,552
41,880
42,039
31,457
30,894
29,020
30,645
23,986
23,152
42,279
50,066
67,599
137,346
142,567
145,428
146,514
161,032
155,261
158,010
161,059
146,458
157,780
213,887
193,706
203,677
242,884
259,705
246,578
246,731
264,463
255,213
269,476
263,911
296,128
294,490
279,297
251,955
261,106
250,593
282,813
267,782
279,506
275,065
256,286
252,408
206,398
190,880
242,588
55,164
55,164242,588190,880206,398252,408256,286275,065279,506267,782282,813250,593261,106251,955279,297294,490296,128263,911269,476255,213264,463246,731246,578259,705242,884203,677193,706213,887157,780146,458161,059158,010155,261161,032146,514145,428142,567137,34667,59950,06642,27923,15223,98630,64529,02030,89431,45742,03941,88040,55240,04138,32935,88534,57434,57733,30540,19821,51357,00357,75457,49464,07361,63071,34773,86683,31383,56282,83483,21583,75782,07481,16581,26755,82952,87753,07553,10653,60054,78356,1807,4118,76810,12810,96512,7299,8241,7911,8631,3351,1041,1461,1831,4148731,4892,2642,6511,4631,7021,933
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,458
30,921
32,726
33,102
34,991
35,295
35,714
36,148
6,797
6,067
5,348
5,278
0
0
4,769
11,079
11,281
110,553
114,326
118,162
122,125
126,263
130,542
134,157
138,531
123,291
142,385
12,766
12,907
13,054
13,212
53
0
0
13,380
12,584
18,813
18,845
18,879
18,913
18,947
12,786
12,823
0
0
0
12,584
12,627
0
0
0
0
0
0
00000012,62712,58400012,82312,78618,94718,91318,87918,84518,81312,58413,380005313,21213,05412,90712,766142,385123,291138,531134,157130,542126,263122,125118,162114,326110,55311,28111,0794,769005,2785,3486,0676,79736,14835,71435,29534,99133,10232,72630,92130,458000000000000000000000000000000000000000000000
       Long term Debt 
1,933
1,702
1,463
2,644
2,264
1,489
873
195
0
0
0
12
0
0
8,082
10,245
8,398
7,408
5,967
4,513
53,042
51,556
50,338
50,044
50,000
50,000
50,000
75,333
75,333
76,347
76,347
77,401
77,401
78,497
78,497
67,836
63,159
48,870
47,966
49,494
49,797
49,193
17,080
34,050
28,722
30,458
30,921
32,726
33,102
34,991
35,295
35,714
36,148
6,797
6,067
5,348
5,278
0
0
4,769
11,079
11,281
110,553
114,326
118,162
122,125
126,263
130,542
134,157
138,531
123,291
142,385
12,766
12,907
13,054
13,212
5,859
0
0
13,380
12,584
18,813
18,845
18,879
18,913
18,947
12,786
12,823
0
0
0
12,584
12,627
12,673
12,720
12,768
0
0
0
00012,76812,72012,67312,62712,58400012,82312,78618,94718,91318,87918,84518,81312,58413,380005,85913,21213,05412,90712,766142,385123,291138,531134,157130,542126,263122,125118,162114,326110,55311,28111,0794,769005,2785,3486,0676,79736,14835,71435,29534,99133,10232,72630,92130,45828,72234,05017,08049,19349,79749,49447,96648,87063,15967,83678,49778,49777,40177,40176,34776,34775,33375,33350,00050,00050,00050,04450,33851,55653,0424,5135,9677,4088,39810,2458,08200120001958731,4892,2642,6441,4631,7021,933
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,343
8,530
9,556
9,367
16,228
16,987
16,726
36,015
37,245
37,066
41,268
44,736
50,132
66,488
65,715
65,269
74,102
74,052
75,915
65,098
75,305
67,449
0
067,44975,30565,09875,91574,05274,10265,26965,71566,48850,13244,73641,26837,06637,24536,01516,72616,98716,2289,3679,5568,5307,3430000000000000000000000000000000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,879
33,398
26,917
26,917
26,917
26,917
26,917
26,917
26,917
22,596
18,275
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000018,27522,59626,91726,91726,91726,91726,91726,91726,91733,39839,879000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
8
0
0
0
1,219
1,183
1,146
1,104
1,323
1,863
1,791
1,742
2,484
2,567
2,720
2,801
2,898
3,138
3,226
3,262
3,063
3,075
2,876
5,830
5,934
5,832
5,728
7,410
5,814
5,433
5,065
4,816
6,030
8,188
12,760
16,107
8,000
7,957
7,809
4,432
6,148
4,583
4,118
3,654
3,159
5,228
5,050
5,257
6,166
5,891
24,660
24,827
23,673
25,368
23,986
23,152
37,511
38,988
56,318
26,793
28,241
27,266
24,389
34,769
24,120
23,323
22,064
22,767
15,061
200,851
180,468
190,444
189,690
220,395
212,375
211,569
216,146
200,356
207,958
202,975
216,201
217,794
207,267
200,269
205,856
203,169
218,241
203,965
191,326
185,670
170,785
0
0
0
0
0
00000170,785185,670191,326203,965218,241203,169205,856200,269207,267217,794216,201202,975207,958200,356216,146211,569212,375220,395189,690190,444180,468200,85115,06122,76722,06423,32324,12034,76924,38927,26628,24126,79356,31838,98837,51123,15223,98625,36823,67324,82724,6605,8916,1665,2575,0505,2283,1593,6544,1184,5836,1484,4327,8097,9578,00016,10712,7608,1886,0304,8165,0655,4335,8147,4105,7285,8325,9345,8302,8763,0753,0633,2623,2263,1382,8982,8012,7202,5672,4841,7421,7911,8631,3231,1041,1461,1831,2190008000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,276
1,193
1,080
1,031
945
1,291
1,365
1,473
1,620
1,653
20,479
13,285
20,884
20,096
34,500
21,744
39,947
11,295
13,175
13,066
10,753
21,772
12,374
12,161
11,336
12,446
7,646
12,543
6,173
5,831
5,811
6,584
186,131
180,279
13,033
10,955
17,867
20,494
187,985
10,807
192,439
5,633
3,266
2,585
2,542
2,204
14,700
13,911
180,217
175,379
129,976
127,981
185,659
0
0185,659127,981129,976175,379180,21713,91114,7002,2042,5422,5853,2665,633192,43910,807187,98520,49417,86710,95513,033180,279186,1316,5845,8115,8316,17312,5437,64612,44611,33612,16112,37421,77210,75313,06613,17511,29539,94721,74434,50020,09620,88413,28520,4791,6531,6201,4731,3651,2919451,0311,0801,1931,276000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,843
2,461
2,079
4,197
4,104
3,966
4,801
4,419
3,949
3,571
3,194
3,148
3,102
3,056
3,010
17,244
16,371
15,498
15,066
14,201
13,636
12,997
12,345
11,692
11,192
10,720
7,748
1,755
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000001,7557,74810,72011,19211,69212,34512,99713,63614,20115,06615,49816,37117,2443,0103,0563,1023,1483,1943,5713,9494,4194,8013,9664,1044,1972,0792,4612,843000000000000000000000000000000000000000000000
> Total Stockholder Equity
114,490
110,711
106,681
116,703
110,168
102,597
89,221
75,925
120,620
106,695
93,211
77,757
123,871
108,987
123,015
105,246
142,015
139,185
123,296
106,443
88,174
66,987
49,797
31,899
16,084
3,047
-6,975
-17,393
-25,191
-34,507
-39,496
-47,060
-30,538
-19,929
-29,889
-23,918
-30,698
-28,582
-18,910
-16,975
-24,408
-19,743
-25,080
-14,707
-12,457
-17,152
-16,071
-26,411
-16,212
-16,940
-13,157
-17,600
-22,684
-17,263
-2,877
-4,481
63,285
57,633
48,870
23,018
46,259
87,190
76,976
70,728
44,453
16,877
-21,039
-39,126
8,905
-17,481
-51,594
-75,816
-113,387
-112,707
-130,408
-172,467
-116,134
-157,228
-199,687
-225,356
-195,922
-218,622
-198,488
-203,672
-189,660
-247,118
41,854
34,440
15,718
3,416
-20,385
-61,278
-58,536
-93,195
-129,112
-160,331
-201,430
-241,311
-87,326
-87,326-241,311-201,430-160,331-129,112-93,195-58,536-61,278-20,3853,41615,71834,44041,854-247,118-189,660-203,672-198,488-218,622-195,922-225,356-199,687-157,228-116,134-172,467-130,408-112,707-113,387-75,816-51,594-17,4818,905-39,126-21,03916,87744,45370,72876,97687,19046,25923,01848,87057,63363,285-4,481-2,877-17,263-22,684-17,600-13,157-16,940-16,212-26,411-16,071-17,152-12,457-14,707-25,080-19,743-24,408-16,975-18,910-28,582-30,698-23,918-29,889-19,929-30,538-47,060-39,496-34,507-25,191-17,393-6,9753,04716,08431,89949,79766,98788,174106,443123,296139,185142,015105,246123,015108,987123,87177,75793,211106,695120,62075,92589,221102,597110,168116,703106,681110,711114,490
   Common Stock
248
248
248
273
274
274
290
290
331
331
331
331
394
395
395
395
451
451
455
455
456
456
456
456
458
458
458
458
459
459
476
476
567
658
664
665
671
785
900
900
915
990
993
1,119
1,136
1,143
214
215
228
239
246
246
253
287
353
364
622
627
627
627
708
843
846
864
865
869
871
878
987
996
997
1,017
1,033
1,112
1,184
1,200
1,342
1,373
1,374
1,378
1,633
1,714
1,892
1,961
2,179
2,253
2,475
2,569
2,667
2,829
2,949
3,056
3,417
3,675
3,814
3,944
210
211
217
2172112103,9443,8143,6753,4173,0562,9492,8292,6672,5692,4752,2532,1791,9611,8921,7141,6331,3781,3741,3731,3421,2001,1841,1121,0331,0179979969878788718698658648468437086276276276223643532872532462462392282152141,1431,1361,119993990915900900785671665664658567476476459459458458458458456456456456455455451451395395395394331331331331290290274274273248248248
   Retained Earnings -2,137,021-2,070,635-2,017,554-1,955,668-1,909,378-1,847,177-1,778,161-1,709,907-1,638,814-1,584,592-1,538,158-1,489,833-1,424,322-1,602,874-1,519,584-1,465,907-1,428,300-1,377,147-1,329,667-1,284,993-1,254,938-1,209,464-1,158,830-1,177,311-1,129,557-1,096,431-1,071,760-1,026,476-991,441-954,600-923,643-905,329-879,206-838,429-810,966-779,187-763,580-750,458-710,048-691,306-665,328-657,219-649,178-649,092-643,315-635,996-624,854-619,019-613,579-607,850-600,927-607,695-601,674-596,140-590,382-584,418-582,002-576,295-571,323-562,512-564,372-553,759-541,671-527,337-532,595-521,664-509,710-498,639-491,179-480,393-470,540-461,844-450,307-439,286-425,197-409,963-392,246-374,991-353,863-335,860-318,412-299,937-296,853-279,698-261,642-243,875-227,256-213,764-197,436-183,880-169,775-157,886-144,081-129-91,653-84,346-51,577-46,826-41,980
   Accumulated Other Comprehensive Income 
-1,745
-1,378
-1,317
-1,477
-1,468
-101,111
-1,203
-716
-671
-612
-673
-173
-178
4
40
91
-59
-292
-187
-175
-185
-115
-109
-91
-70
-52
-28
-22
-7
-7
0
-22,628
-22,628
-22,628
-22,628
-25,881
-25,881
0
0
-28,613
-28,965
-29,510
-30,149
-24,993
-25,145
-25,639
-25,941
-26,082
-26,627
-27,170
-27,343
-27,405
-27,389
-27,414
-27,535
-27,637
215
136
-1,157
-1,970
-1,206
-658
-1,332
-2,053
-1,515
-1,658
-1,560
-1,530
-1,661
-2,290
-2,059
-2,169
-2,706
-1,578
-1,616
-1,539
-2,221
-1,079
-1,282
-1,324
-97
369
1,233
2,772
-1,002
260
177
1,492
970
2,149
644
915
917
-717
-1,028
-955
-1,071
-1,001
-1,347
-1,347-1,001-1,071-955-1,028-7179179156442,1499701,492177260-1,0022,7721,233369-97-1,324-1,282-1,079-2,221-1,539-1,616-1,578-2,706-2,169-2,059-2,290-1,661-1,530-1,560-1,658-1,515-2,053-1,332-658-1,206-1,970-1,157136215-27,637-27,535-27,414-27,389-27,405-27,343-27,170-26,627-26,082-25,941-25,639-25,145-24,993-30,149-29,510-28,965-28,61300-25,881-25,881-22,628-22,628-22,628-22,6280-7-7-22-28-52-70-91-109-115-185-175-187-292-5991404-178-173-673-612-671-716-1,203-101,111-1,468-1,477-1,317-1,378-1,745
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
578,169
585,714
581,393
584,811
590,995
594,920
595,917
596,661
618,771
640,409
644,572
711,625
714,089
714,728
715,668
756,804
837,464
841,041
851,104
856,068
856,107
858,855
866,854
933,222
938,412
940,908
951,812
960,047
984,189
999,581
1,005,183
1,043,575
1,051,942
1,055,159
1,059,583
1,132,209
1,156,442
1,226,687
1,257,502
1,328,747
1,353,243
1,463,524
1,520,212
1,550,239
1,583,030
1,614,836
1,644,658
1,715,291
0
0
0
0
0
0
0000001,715,2911,644,6581,614,8361,583,0301,550,2391,520,2121,463,5241,353,2431,328,7471,257,5021,226,6871,156,4421,132,2091,059,5831,055,1591,051,9421,043,5751,005,183999,581984,189960,047951,812940,908938,412933,222866,854858,855856,107856,068851,104841,041837,464756,804715,668714,728714,089711,625644,572640,409618,771596,661595,917594,920590,995584,811581,393585,714578,169000000000000000000000000000000000000000000000
   Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-12
-99
-99
-270
-270
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
-325
325
325
325
-325
0
0
0
0
0
0
0
0
0
-13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000-13000000000-325325325325-325-325-325-325-325-325-325-325-325-325-325-325-325-325-325-325-270-270-99-99-120000000000000000000000000000000
   Other Stockholders Equity 
157,940
158,666
159,326
202,253
203,015
106,746
234,216
234,237
290,736
290,856
290,988
291,363
350,912
352,463
384,222
384,458
438,476
438,963
441,440
442,022
441,766
441,637
441,696
441,497
440,893
441,926
442,902
444,014
444,898
445,433
451,207
473,731
501,232
523,704
524,671
528,634
510,302
524,392
544,562
573,250
574,965
585,072
586,078
593,585
601,934
603,483
611,330
607,150
611,114
617,841
627,519
628,578
629,305
645,859
667,619
671,884
711,625
714,089
714,728
715,667
756,804
837,464
841,041
851,104
856,068
856,094
858,855
866,855
933,222
938,412
940,908
951,812
960,047
984,189
999,581
1,005,183
1,010,177
1,025,025
1,028,242
1,032,666
1,105,292
1,129,525
1,199,770
1,230,585
1,306,151
1,334,968
1,025,885
1,054,254
1,550,239
1,583,030
1,614,836
1,231,102
1,715,291
1,751,024
1,777,480
1,792,348
1,816,985
1,830,114
2,050,825
2,050,8251,830,1141,816,9851,792,3481,777,4801,751,0241,715,2911,231,1021,614,8361,583,0301,550,2391,054,2541,025,8851,334,9681,306,1511,230,5851,199,7701,129,5251,105,2921,032,6661,028,2421,025,0251,010,1771,005,183999,581984,189960,047951,812940,908938,412933,222866,855858,855856,094856,068851,104841,041837,464756,804715,667714,728714,089711,625671,884667,619645,859629,305628,578627,519617,841611,114607,150611,330603,483601,934593,585586,078585,072574,965573,250544,562524,392510,302528,634524,671523,704501,232473,731451,207445,433444,898444,014442,902441,926440,893441,497441,696441,637441,766442,022441,440438,963438,476384,458384,222352,463350,912291,363290,988290,856290,736234,237234,216106,746203,015202,253159,326158,666157,940



5.4. Balance Sheets

Currency in USD. All numbers in thousands.